Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dhuper, S.
Right arrow Articles by Shim, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dhuper, S.
Right arrow Articles by Shim, C.
(Chest. 2006;130:1063-1071.)
© 2006 American College of Chest Physicians

Room Air Entrainment During ß-Agonist Delivery With Heliox*

Sunil Dhuper, MD; Sonia Choksi, MD; Simdararajan Selvaraj, MD; Gautam Jha, MD; Aziz Ahmed, MD; Harsh Babbar, MD; Baljit Walia, MD; Alpana Chandra, MD; Virginia Chung, MD and Chang Shim, MD

* From the Department of Medicine (Drs. Dhuper, Choksi, Selvaraj, Jha, Ahmed, Babbar, Walia, Chandra, and Chung), North Central Bronx Hospital, Bronx, NY; and the Department of Medicine (Dr. Shim), Jacobi Medical Center, Bronx, NY.

Correspondence to: Sunil Dhuper, MD, North Central Bronx Hospital, Medicine, 3424 Kossuth Ave, Bronx, NY 10467; e-mail: sunil.dhuper{at}nychhc.org

Abstract

Studies of the efficacy of heliox in patients with severe asthma have shown mixed results. Among the factors that are responsible for variable outcomes, the failure of heliox delivery systems to prevent room air entrainment (RAE) during ß-agonist delivery is probably the most critical. While keeping the rotameter flow rate (FR) of heliox mixed 70:30 to a nebulizer at 10 L/min, the FR of heliox from a second gas source to a T-connector (TC) was increased during the delivery of the ß-agonist with a conventional T-nebulizer delivery system (TNDS). A negative peak inspiratory flow (pneumotachometer reading) or a helium concentration of < 70% (quadralizer reading) were indicators of RAE. RAE was tested during spontaneous tidal breathing and acute asthma. A rotameter FR of 10 L/m to the nebulizer with no flow from a second gas source to a TC (conventional TNDS) resulted in a significant drop in helium concentration during tidal breathing (46.2%) and acute asthma (27.5%) due to RAE. This degree of helium dilution can negate the beneficial effects of heliox to lung mechanics almost completely. A rotameter FR of 10 L/m each to a nebulizer and a TC resulted in a helium concentration 69.8% during tidal breathing (no RAE), but 49% (significant RAE) during asthma events. A rotameter FR of 15 L/m (pressure regulator setting, 100 lbs per square inch) to a TC, while maintaining a rotameter FR of 10 L/m to a nebulizer prevented RAE during asthma (helium concentration, 69.9%). Conventional TNDS may be used to deliver the ß-agonist with heliox during asthma without RAE.

Key Words: ß-agonist delivery • heliox • nebulizer • room air entrainment






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American College of Chest Physicians.